Sign in

CIK 0001659617

  • Non-accelerated filer
  • Smaller reporting company

Moleculin Biotech, Inc.

Sign in to watch
Ticker
MBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474671997
Phone
+1 713-300-5160
Business address
5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
  1. 4 Shares withheld for taxes Chief Science Officer gave up 320 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 636 shares (to pay taxes)
  3. 4 Shares withheld for taxes CEO and President gave up 914 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Financial Officer gave up 196 shares (to pay taxes)
  5. 4 Shares withheld for taxes CEO and President gave up 406 shares (to pay taxes)
  6. 4 Open-market buy Chief Financial Officer bought 28,986 shares at $0.69 ($20,000)
  7. 4 Open-market buy Director bought 14,493 shares at $0.69 ($10,000)
  8. 4 Open-market buy CEO and President bought 188,404 shares at $0.69 ($129,999)
  9. 4 Shares withheld for taxes CEO and President gave up 3,216 shares (to pay taxes)
  10. 4 Shares withheld for taxes CEO and President gave up 3,584 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes Chief Science Officer gave up 4,267 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 9,676 shares (to pay taxes)
  16. 4 Shares withheld for taxes CEO and President gave up 13,697 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 3,044 shares (to pay taxes)
  18. 4 Shares withheld for taxes CEO and President gave up 6,088 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 8 · 143 filings